U.S. Drugmakers Face New Intellectual Property Hurdles in China

September 25, 2019

The U.S. pharmaceutical industry wants a piece of China’s market of 1.4 billion people, but protecting its intellectual property remains a challenge, despite sweeping new changes in Chinese law.

Related Stories